Detalhe da pesquisa
1.
PARP-1 selectively impairs KRAS-driven phenotypic and molecular features in intrahepatic cholangiocarcinoma.
Gut
; 2024 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38857989
2.
Transcriptional Response to Standard AML Drugs Identifies Synergistic Combinations.
Int J Mol Sci
; 24(16)2023 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37629110
3.
Synergistic targeting of FLT3 mutations in AML via combined menin-MLL and FLT3 inhibition.
Blood
; 136(21): 2442-2456, 2020 11 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32589720
4.
Targeting components of the alternative NHEJ pathway sensitizes KRAS mutant leukemic cells to chemotherapy.
Blood
; 123(15): 2355-66, 2014 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24505083
5.
SIRT1 prevents genotoxic stress-induced p53 activation in acute myeloid leukemia.
Blood
; 124(1): 121-33, 2014 Jul 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-24855208
6.
Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusions.
Nat Commun
; 15(1): 51, 2024 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38168093
7.
Targeting Bcl-2 family proteins modulates the sensitivity of B-cell lymphoma to rituximab-induced apoptosis.
Blood
; 112(8): 3312-21, 2008 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18689543
8.
STAT5 is crucial to maintain leukemic stem cells in acute myelogenous leukemias induced by MOZ-TIF2.
Cancer Res
; 73(1): 373-84, 2013 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23149921
9.
Pharmacologic inhibition of mTOR antagonizes the cytotoxic activity of pemetrexed in non-small cell lung cancer.
J Cancer Res Clin Oncol
; 138(4): 545-54, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22203472
10.
Functional and clinical characterization of the putative tumor suppressor WWOX in non-small cell lung cancer.
J Thorac Oncol
; 6(12): 1976-83, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21892104
11.
Perforin deficiency attenuates inflammation and tumor growth in colitis-associated cancer.
Inflamm Bowel Dis
; 16(4): 559-67, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19785028
12.
RASSF1A mediates p21Cip1/Waf1-dependent cell cycle arrest and senescence through modulation of the Raf-MEK-ERK pathway and inhibition of Akt.
Cancer Res
; 69(5): 1748-57, 2009 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19223555
13.
Targeting AKT signaling sensitizes cancer to cellular immunotherapy.
Cancer Res
; 68(10): 3899-906, 2008 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18483275
14.
An immune escape screen reveals Cdc42 as regulator of cancer susceptibility to lymphocyte-mediated tumor suppression.
Blood
; 111(3): 1413-9, 2008 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17971488